Physiological flow model for drug elimination interactions in the rat

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Computational Modeling
• Toxicology

Background:

• Drug-drug interactions (DDIs) significantly impact therapeutic efficacy and safety.
• Accurate modeling of drug elimination pathways is crucial for predicting DDIs.
• Previous models lacked comprehensive representation of all elimination compartments.

Purpose of the Study:

• To develop and validate an enhanced physiologically based pharmacokinetic (PBPK) model for simulating drug elimination interactions in rats.
• To incorporate skin as a distinct compartment and Michaelis-Menten kinetics for competitive inhibition.
• To enable simulation of repetitive dosing scenarios for improved DDI prediction.

Main Methods:

• Physiologically based modeling incorporating blood flow rates and organ weights.
• Inclusion of a skin compartment in the PBPK model.
• Application of Michaelis-Menten kinetics to model competitive inhibition in shared metabolic pathways.
• Simulation of acute and repetitive drug administration.

Main Results:

• The enhanced model accurately predicts drug elimination interactions.
• The addition of the skin compartment improved model performance.
• Simulations demonstrated the model's capability to handle competitive inhibition and repetitive dosing.
• Model validation was performed using an acute warfarin-BSP interaction experiment in rats.

Conclusions:

• The improved PBPK model provides a more comprehensive platform for studying drug elimination interactions in rats.
• The model's ability to simulate competitive inhibition and repetitive dosing enhances its utility in preclinical drug development.
• This computational tool aids in predicting potential DDIs and optimizing dosing regimens.